Recalls from Accriva Diagnostics, Inc.

• Accriva Diagnostics Hemochron Jr. APTT Test Cuvettes (opens in a new tab)
  Moderate risk, FDA, Oct 30, 2026, Device defect
• DirectCHECK ACT-LR Whole Blood Quality Control, Level 2 (opens in a new tab)
  Moderate risk, FDA, Jun 16, 2026, Labeling error

Data: Recall Canary (opens in a new tab)